[1S-(1alpha,6alpha,7beta,7aalpha)]-6-acetoxy-6,7a-dihydro-4-[(isovaleryloxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1-yl isovalerate

[1S-(1alpha,6alpha,7beta,7aalpha)]-6-acetoxy-6,7a-dihydro-4-[(isovaleryloxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1-yl isovalerate 구조식 이미지
카스 번호:
31078-10-1
상품명:
[1S-(1alpha,6alpha,7beta,7aalpha)]-6-acetoxy-6,7a-dihydro-4-[(isovaleryloxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1-yl isovalerate
동의어(영문):
Einecs 250-454-0;[1S-(1alpha,6alpha,7beta,7aalpha)]-6-acetoxy-6,7a-dihydro-4-[(isovaleryloxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1-yl isovalerate;(1S-(1alpha,6alpha,7beta,7Aalpha))-6-acetoxy-6,7A-dihydro-4-((isovaleryloxy)methyl)spiro(cyclopenta(C)pyran-7(1H),2'-oxiran)-1-yl isovalerate;3-Methylbutanoic acid [(1S,7R)-6α-acetoxy-6,7aα-dihydro-4-[(3-methyl-1-oxobutoxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1α-yl] ester;Butanoic acid, 3-methyl-, (1S,2'R,6S,7aS)-6-(acetyloxy)-6,7a-dihydro-4-[(3-methyl-1-oxobutoxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1-yl ester
CBNumber:
CB9883176
분자식:
C22H30O8
포뮬러 무게:
422.47
MOL 파일:
31078-10-1.mol

[1S-(1alpha,6alpha,7beta,7aalpha)]-6-acetoxy-6,7a-dihydro-4-[(isovaleryloxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1-yl isovalerate 속성

끓는 점
525.9±50.0 °C(Predicted)
밀도
1.22±0.1 g/cm3(Predicted)

안전

[1S-(1alpha,6alpha,7beta,7aalpha)]-6-acetoxy-6,7a-dihydro-4-[(isovaleryloxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1-yl isovalerate C화학적 특성, 용도, 생산

[1S-(1alpha,6alpha,7beta,7aalpha)]-6-acetoxy-6,7a-dihydro-4-[(isovaleryloxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1-yl isovalerate 준비 용품 및 원자재

원자재

준비 용품


[1S-(1alpha,6alpha,7beta,7aalpha)]-6-acetoxy-6,7a-dihydro-4-[(isovaleryloxy)methyl]spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-1-yl isovalerate 공급 업체

글로벌( 4)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Baoji Didu Pharmaceutical and Chemical Co., Ltd 029-61856358 15829046862
1035@dideu.com China 10011 58
Carbosynth --
sales@carbosynth.com United Kingdom 6018 58

Copyright 2019 © ChemicalBook. All rights reserved